In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top stocks everyone is talking about these days. Major AI stocks are wavering as investors ...

Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the ...

Tempus AI has a twelve month low of $22.89 and a twelve month high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Insider Activity ...

Popular investor Cathie Wood and her Ark Invest funds took advantage of a buying opportunity on Tuesday by purchasing over 400,000 shares of Tempus AI (TEM) as the stock plummeted 15%. This move ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley Technology, Media & Telecom ...

Tempus AI, Inc. Class A (TEM – Research Report) received a Hold rating and price target from William Blair analyst Andrew Brackmann today. The company’s shares closed yesterday at $89.44 ...

The financing is intended to support Tempus’ previously announced acquisition of Ambry Genetics (“Ambry”), which closed on February 3, 2025. Combined with $260 million of capital provided in ...

Tempus AI (NASDAQ: TEM) is a leader in precision medicine and artificial intelligence (AI) in the healthcare sector. Tempus AI’s stock price has seen an increase, with gains of over 160% in the ...

TEM also has other innovative assets like xT CDx, xH tests, and enhanced Tempus One that I think position it perfectly for agentic AI diagnostics. However, note that TEM now trades at a relatively ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other stocks. Wall Street extended a lackluster performance on Tuesday, with two of its major ...